drugset / Trial / NCT02063139
Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
RandomizedCrossoverSingle-blindTreatment
Summary
Aim of the study is to investigate the short-term growth in children with asthma aged 5-11 years in treatment with fluticasone propionate / formoterol spray (flutiform®) 200/20 micrograms per day
Timeline
- Start
- 2014-02
- Primary completion
- 2014-06
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone | Small molecule | 50 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 50 ug | Inhaled |
| Subject | Flutiform | Unknown | — | Inhaled |